Metraipolis › archive › dc_a175dc77340b

Clinical benefit of additional whole-exome sequencing over panel sequencing in an all-comer real-world molecular tumor board — Europe PMC PMID:41297163

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41297163
DOI
10.1016/j.esmoop.2025.105894
License (as archived)
solo-consultazione
Archived
2026-11-08T06:47:42.300Z
SHA-256 of the archived text
3cf449c296fc811ea72e1b578268e7c846510c5a87c3bdacf6748701170ca6fd
Stable URL of this page
https://metraipolis.com/documento/dc_a175dc77340b

How to cite

Clinical benefit of additional whole-exome sequencing over panel sequencing in an all-comer real-world molecular tumor board — Europe PMC PMID:41297163 — Europe PMC (en), https://europepmc.org/article/MED/41297163 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a175dc77340b (Metraipolis archive dc_a175dc77340b, sha256 3cf449c296fc811ea72e1b578268e7c846510c5a87c3bdacf6748701170ca6fd)
BibTeX
@misc{dca175dc77340b,
  title = {Clinical benefit of additional whole-exome sequencing over panel sequencing in an all-comer real-world molecular tumor board — Europe PMC PMID:41297163},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41297163},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a175dc77340b; sha256 3cf449c296fc811ea72e1b578268e7c846510c5a87c3bdacf6748701170ca6fd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41297163. Agents can read the archived copy with the MCP tool read_document.